MeSH tree: B01.043.075.380.611
Malaria is a devastating disease caused by the Plasmodium parasite. After an infected mosquitos' bite, the parasites travel to the liver and infect liver cells. This phase of the infection is asymptomatic.
Nov 9, 2022
0
80
Research in Africa found a one-time dose of an experimental drug protected adults against malaria for at least six months, the latest approach in the fight against the mosquito-borne disease.
Nov 5, 2022
0
129
Scientists say an invasive mosquito species was likely responsible for a large malaria outbreak in Ethiopia earlier this year, a finding that experts called a worrying sign that progress against the disease is at risk of ...
Nov 1, 2022
0
117
One dose of an antibody drug safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Mali, Africa, a National Institutes of Health clinical trial has found. The antibody ...
Oct 31, 2022
0
98
Malaria is caused by the parasite Plasmodium falciparum, which is transmitted by mosquitos. The World Health Organization (WHO) estimates that in 2020, there were 241 million cases and 627,000 deaths worldwide, 94% of cases ...
Oct 13, 2022
0
38
Researchers from the Walter Reed Army Institute of Research (WRAIR) report the malaria vaccine FMP013 antigen and ALFQ adjuvant combination appears safe and immunogenic for adults in the first-in-human evaluation results ...
Sep 14, 2022
0
59
The drug artemisinin is the world's most important first-line drug for the treatment of malaria, a disease spread by mosquitoes that was responsible for 627,000 deaths globally in 2020. To prevent the malaria parasite (Plasmodium ...
Aug 29, 2022
1
73
Findings from a preliminary human study of an experimental, genetically attenuated malaria parasite immunization show this vaccine warrants further exploration.
Aug 24, 2022
0
92
A survey of malaria among pregnant women in Brazil by researchers at the University of São Paulo (USP) has been published in Lancet Regional Health—Americas. According to the researchers, the study is the first to provide ...
Aug 16, 2022
0
72
A large team of researchers affiliated with a host of institutions across the U.S. has developed a monoclonal antibody proven to be effective against malaria, perhaps for as long as six months, in a clinical trial. They have ...
